IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 223 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,673 | -20.6% | 1,026,965 | +22.9% | 0.01% | -12.5% |
| Q2 2023 | $5,882 | +42.1% | 835,494 | +23.4% | 0.01% | +33.3% |
| Q1 2023 | $4,138 | +9.5% | 677,309 | +14.5% | 0.01% | +20.0% |
| Q4 2022 | $3,780 | -99.9% | 591,523 | +4.8% | 0.01% | -37.5% |
| Q3 2022 | $5,408,000 | -11.7% | 564,495 | +1.7% | 0.01% | 0.0% |
| Q2 2022 | $6,125,000 | -29.5% | 554,825 | +6.4% | 0.01% | -11.1% |
| Q1 2022 | $8,686,000 | -12.8% | 521,689 | 0.0% | 0.01% | -10.0% |
| Q4 2021 | $9,959,000 | -36.1% | 521,689 | -17.4% | 0.01% | -41.2% |
| Q3 2021 | $15,574,000 | -8.4% | 631,553 | -3.3% | 0.02% | -5.6% |
| Q2 2021 | $16,997,000 | -16.4% | 653,231 | +1.7% | 0.02% | -18.2% |
| Q1 2021 | $20,327,000 | -35.6% | 642,032 | -5.6% | 0.02% | -37.1% |
| Q4 2020 | $31,559,000 | +37.2% | 680,151 | -2.6% | 0.04% | +25.0% |
| Q3 2020 | $22,995,000 | +20.9% | 698,510 | +0.8% | 0.03% | +16.7% |
| Q2 2020 | $19,017,000 | +40.8% | 692,794 | +53.6% | 0.02% | +20.0% |
| Q1 2020 | $13,505,000 | +16.8% | 451,141 | +8.0% | 0.02% | +42.9% |
| Q4 2019 | $11,563,000 | +78.9% | 417,739 | +17.6% | 0.01% | +75.0% |
| Q3 2019 | $6,464,000 | -19.5% | 355,138 | +8.5% | 0.01% | -20.0% |
| Q2 2019 | $8,027,000 | +785.0% | 327,368 | +243.2% | 0.01% | +900.0% |
| Q1 2019 | $907,000 | +27.2% | 95,400 | +18.4% | 0.00% | 0.0% |
| Q4 2018 | $713,000 | -30.6% | 80,600 | -11.8% | 0.00% | 0.0% |
| Q3 2018 | $1,028,000 | -12.1% | 91,400 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $1,170,000 | -11.9% | 91,400 | +16.3% | 0.00% | -50.0% |
| Q1 2018 | $1,328,000 | +225.5% | 78,600 | +54.1% | 0.00% | – |
| Q4 2017 | $408,000 | +3.3% | 51,000 | 0.0% | 0.00% | -100.0% |
| Q3 2017 | $395,000 | +5.3% | 51,000 | 0.0% | 0.00% | – |
| Q2 2017 | $375,000 | – | 51,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,944,201 | $27,999,000 | 13.31% |
| Broadfin Capital, LLC | 4,328,303 | $41,162,000 | 8.50% |
| GREAT POINT PARTNERS LLC | 5,567,348 | $52,945,000 | 5.24% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $20,811,000 | 5.01% |
| Avoro Capital Advisors LLC | 10,530,862 | $100,148,000 | 4.33% |
| Prosight Management, LP | 917,080 | $8,721,000 | 3.82% |
| Perceptive Advisors | 12,235,811 | $116,362,000 | 3.28% |
| Ghost Tree Capital, LLC | 1,150,000 | $10,937,000 | 2.86% |
| QVT Financial LP | 1,021,361 | $9,241,000 | 2.32% |
| Cheyne Capital Management (UK) LLP | 186,500 | $1,774,000 | 1.66% |